Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Keratosis Pilaris : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Multimedia
References

Related Articles
Acne Vulgaris

Atopic Dermatitis

Eruptive Vellus Hair Cysts

Erythromelanosis follicularis faciei et colli

Folliculitis

Keratosis Follicularis (Darier Disease)

Kyrle Disease

Lichen Nitidus

Lichen Spinulosus

Milia

Perforating Folliculitis

Pityriasis Rubra Pilaris

Trichostasis Spinulosa




Patient Education
Click here for patient education.



Author: Nili N Alai, MD, FAAD, Assistant Clinical Professor, Department of Dermatology, Clinical Faculty and Preceptor, Department of Family Practice, University of California at Irvine; Clinical Faculty and Preceptor, Department of Family Practice, Downey Medical Center Residency Training; CEO, The Skin Center, Mission Viejo and Laguna Hills, California

Nili N Alai is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Micrographic Surgery and Cutaneous Oncology, American Society for Laser Medicine and Surgery, American Society of Cosmetic Dermatology and Aesthetic Surgery, and Women's Dermatologic Society

Coauthor(s): Raul Del Rosario, MD, Consulting Staff, Surgical Pathology and Dermatopathology, South Coast Medical; Azalea Saemi, MBA, University of Vermont; Paimon Dehghanian, Georgia Tech University; Arash Michael Saemi, BS, University of Vermont College of Medicine

Editors: Günter Burg, MD, Professor and Chairman Emeritus, Department of Dermatology, University of Zürich School of Medicine; Delegate of The Foundation for Modern Teaching and Learning in Medicine Faculty of Medicine, University of Zürich, Switzerland; Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center; Rosalie Elenitsas, MD, Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System; Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania; Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center

Author and Editor Disclosure

Synonyms and related keywords: KP, hyperkeratosis, folliculocentric keratotic papules, follicular keratotic papules, atopic dermatitis, ichthyosis vulgaris, excessive accumulation of keratin, benign skin lesion, gooseflesh appearance, erythema, chicken skin bumps

Background

Keratosis pilaris (KP) is a genetic disorder of keratinization of hair follicles of the skin. It is an extremely common benign condition that manifests as small, rough folliculocentric keratotic papules, often described as chicken bumps, chicken skin, or goose bumps, in characteristic areas of the body, particularly the outer-upper arms and thighs. Although no clear etiology has been defined, KP is often described in association with other dry skin conditions such as ichthyosis vulgaris, xerosis, and, less commonly, with atopic dermatitis, including conditions of asthma and allergies. See Ichthyosis Vulgaris, Hereditary and Acquired and Atopic Dermatitis for more information.

KP affects nearly 50-80% of all adolescents and approximately 40% of adults. It is frequently noted in otherwise asymptomatic patients visiting dermatologists for other conditions. Most people with KP are unaware the condition has a designated medical term  or that it is treatable. In general, KP is frequently cosmetically displeasing but medically harmless.

Overall, KP is described as a condition of childhood and adolescence. Although it often becomes more exaggerated at puberty, it frequently improves with age. However, many adults have KP late into senescence. Approximately 30-50% of patients have a positive family history. Autosomal dominant inheritance with variable penetrance has been described.

Seasonal variation is sometimes described, with improvement of symptoms in summer months. Dry skin in winter tends to worsen symptoms for some groups of patients. Overall, KP is self-limited and, again, tends to improve with age in many patients. Some patients have lifelong KP with periods of remissions and exacerbations. More widespread atypical cases may be cosmetically disfiguring and psychologically distressing.

Pathophysiology

KP is a genetically based disorder of hyperkeratinization of the skin. The excess formation and/or buildup of keratin is thought to cause the abrasive goose-bump texture of the skin. The process of keratinization (the formation of epidermal skin) is faulty. One theory is that surplus skin cells build up around individual hair follicles. The individual follicular bumps are often caused by a hair that is unable to reach the surface and becomes trapped beneath the keratin debris. Often, patients develop mild erythema around the hair follicles, which is indicative of the inflammatory condition. Often, a small, coiled hair can be seen beneath the papule. Not all the bumps have associated hairs underneath. Papules are thought to arise from excessive accumulation of keratin at the follicular orifice.

Frequency

International

KP is overall a very common condition and is present worldwide. KP affects 50-80% of adolescents and approximately 40% of adults worldwide.

In India and other countries, a specific condition called erythromelanosis follicularis faciei et colli is described. This is an unusual condition with a possible genetic or other relationship to KP. Erythromelanosis follicularis faciei et colli is characterized by the triad of hyperpigmentation, follicular plugging, and erythema of the face and neck.1, 2

Mortality/Morbidity

KP is not associated with increased mortality or morbidity. Often, patients are bothered by the cosmetic appearance of their skin and its rough, gooseflesh texture. KP is present in otherwise healthy individuals and does not have any long-term health implications.

Race

KP has no widely described racial predilection or predominance. It is commonly noted worldwide in persons of all races.

Sex

Both sexes are affected by KP, but females may be affected more frequently than males.

Age

Age of onset is often within the first decade of life; symptoms particularly intensify during puberty. However, KP may manifest in persons of any age and is common in young children. Some believe individuals can outgrow the disorder by early adulthood, but often this is not the case.



History

Patients often report a rough texture (gooseflesh appearance) and overall poor cosmetic appearance of their skin. Eruption is usually asymptomatic, except for occasional pruritus.

Physical

Physical findings are limited to the skin. Upon gross examination, the skin of the outer upper arms and thighs is frequently affected. The skin is described as chicken skin or goose bumps. Often, 10-100 very small slightly rough bumps are scattered in an area. Palpation may reveal a fine, sandpaperlike texture to the area. Some of the bumps may be slightly red or have an accompanying light-red halo indicating inflammation. In some instances, scratching away the surface of some bumps may reveal a small, coiled hair.

Small (up to 1-2 mm) folliculocentric keratotic papules are noted (see Media File 1). These are small bumps centered on small hair follicles. Some associated inflammation (erythema) may be present, and lesions may be the color of the skin. Often, a small, coiled hair can be seen beneath the papule. In other instances, a keratin plug or pimplelike material may be expressed from each bump. Pustules and cysts are fairly rare. 

Commonly involved areas include posterolateral upper arms (see Media File 2), anterior thighs, buttocks, and facial cheeks. The single most characteristic area in KP is the upper outer arms.

Causes

The etiology of KP is not fully known. The definite association of hyperkeratinization has been established. Of those affected, 50-70% have a genetic predisposition. Dry skin conditions seem to exacerbate the disease. Symptoms generally tend to worsen in winter and improve in summer. Common associations include a family history of KP, ichthyosis, or atopic dermatitis.3



Acne Vulgaris
Atopic Dermatitis
Eruptive Vellus Hair Cysts
Erythromelanosis follicularis faciei et colli
Folliculitis
Keratosis Follicularis (Darier Disease)
Kyrle Disease
Lichen Nitidus
Lichen Spinulosus
Milia
Perforating Folliculitis
Pityriasis Rubra Pilaris
Trichostasis Spinulosa

Other Problems to be Considered

KP may be associated with phrynoderma (vitamin A deficiency). Interestingly, a significant association was also found between acquired ichthyosis and KP as common cutaneous manifestations in persons with type 1 diabetes.



Lab Studies

No specific laboratory tests aid in diagnosis.

Imaging Studies

Imaging studies are not indicated.

Procedures

Skin biopsy with histopathological examination may be useful in atypical cases.

Histologic Findings

Papules are thought to arise from excessive accumulation of keratin at the follicular orifice. The epidermis shows mild hyperkeratosis, hypergranulosis, and follicular plugging. The upper dermis may have some mild superficial perivascular lymphocytic inflammatory changes.



Medical Care

In view of the described genetic predisposition and genetic etiology, no cure or universally effective treatment is available. Inconsistent remissions and variations with seasons and hormonal states (eg, pregnancy4) are described. Although symptoms usually remit with increasing age, this is not always the case.

  • General measures to prevent excessive skin dryness and use of mild cleansers (eg, Dove, Cetaphil) are recommended.
  • Some available therapeutic options include emollients, lactic acid, tretinoin cream, tazarotene, alpha-hydroxy acid lotions and peels, urea cream, salicylic acid, topical steroids, and topical immunomodulators. Pulse weekly topical retinoids are generally the most effective, but the response usually is not complete. Vitamin D (calcipotriol) is not effective for KP, but clinical trials have found it moderately effective for ichthyoses.5
  • Aminolevulinic acid (Levulan) photodynamic therapy has been anecdotally reported as effective,  but this successful use of off-label photodynamic therapy requires confirmation.
  • Microdermabrasion is described as machine-assisted fine abrasion of the skin using vacuum suction and debris removal. An abrasive particle such as fine powdery crystals or diamond tip is used to remove the keratin and outer layers of the epidermis in a controlled manner. As with other treatments for KP, data exists only in the form of small group observations and anecdotal reports. Because KP is generally a chronic condition that requires long-term maintenance, most therapies would require repeated or long-term use to maintain results. An additional option to in-office microdermabrasion is manual gentle exfoliation using a loofah sponge or a commercially available Buf-Puff sponge.

Surgical Care

Surgery is not indicated.

Consultations

Consultation with a dermatologist is appropriate for refractory or widespread cases.

Diet

KP has no dietary associations.

Activity

KP does not limit any patient activities.



The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Drug Category: Retinoids

Retinoic acid decreases cohesiveness of follicular epithelial cells, stimulates mitotic activity, and increases turnover of follicular epithelial cells.

Drug NameTretinoin (Retin-A, Avita)
DescriptionInhibits microcomedo formation and eliminates lesions present. Makes keratinocytes in sebaceous follicles less adherent and easier to remove. Available as 0.025%, 0.05%, and 0.1% creams. Available also as 0.01%, 0.025%, 0.04%, and 0.1% gels.
Adult DoseBegin with lowest tretinoin formulation and increase as tolerated; apply hs or qod; decrease frequency of application if irritation develops
Pediatric Dose<12 years: Not established
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity to tretinoin or parabens
InteractionsToxicity increases with coadministration of benzoyl peroxide, salicylic acid, and resorcinol; avoid topical sulfur, resorcinol, salicylic acid, other keratolytics, abrasives, astringents, spices, and lime
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
PrecautionsPhotosensitivity may occur with excessive sunlight exposure; caution in eczema; do not apply to mucous membranes, mouth, and angles of nose

Drug Category: Alpha-hydroxy acids

Normal constituent of tissues and blood. Act as humectants when applied topically and may decrease corneocyte cohesion.

Drug NameAmmonium lactate lotion (AmLactin, Lac Hydrin)
DescriptionIndicated for treatment of ichthyosis vulgaris and xerosis. Contains lactic acid, an alpha-hydroxy acid that has keratolytic action, thus facilitating release of comedones. Causes disadhesion of corneocytes. Use 12% cream or lotion.
Adult DoseApply bid to affected skin
Pediatric Dose<12 years: Not established
>12 years: Apply as in adults
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsMay sting or cause pain if applied to broken skin; may cause irritation with erythema, burning, and peeling if applied to face at 12% concentration; avoid contact with eyes, mucous membranes, and lips; minimize sun exposure because of possibility of heightened photosensitivity

Drug Category: Topical Skin Product

Drug NameUrea
DescriptionPromotes hydration and removal of excess keratin in conditions of hyperkeratosis.
Available in 10-40% concentrations.
Adult DoseApply prn to affected areas
Pediatric Dose10-20% concentrations acceptable in adolescents; caution with 30-40% concentrations in pediatric patients
Apply bid
ContraindicationsDocumented hypersensitivity; severely impaired renal function, active intracranial bleeding, marked dehydration, frank liver failure; infusion into veins of lower extremities in elderly may cause phlebitis and thrombosis
InteractionsMay decrease effects of lithium
PregnancyD - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
PrecautionsDo not use if intracranial bleeding present, unless prior to surgical intervention to control hemorrhage (reduction of brain edema by urea may result in reactivation of intracranial bleeding); may increase risk of venous thrombosis and hemoglobinuria in hypothermic patients; caution in renal impairment

Drug Category: Keratolytic Agent

Drug NameTazarotene (Tazorac)
DescriptionReceptor-selective retinoid is a synthetic retinoid prodrug that is rapidly converted into tazarotenic acid. Because use of tretinoin often is hampered by its irritancy, this product may be advantageous. Available as 0.05% and 0.1% cream or gel.
Adult DoseApply 0.05% gel every other night for 2 wk initially, then may increase to nightly as tolerated
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsDo not use concomitantly with dermatologic drugs or cosmetics that have a strong drying effect on the skin (eg, salicylic acid, benzoyl peroxide, astringents)
PregnancyX - Contraindicated; benefit does not outweigh risk
PrecautionsMay cause burning or stinging sensations; discontinue if excessive irritation; rinse thoroughly if contact with eyes, eyelids, or mouth; may cause severe irritation in eczematous skin; photosensitivity may occur

Drug Category: Acne Products

Drug NameAdapalene (Differin)
DescriptionModulates cellular differentiation, inflammation, and keratinization. May be tolerated by individuals who cannot tolerate tretinoin creams. A therapeutic response can be expected following 8-12 wk of therapy. Available as 0.1% gel or solution or 0.3% gel.
Adult DoseApply hs; some patients may tolerate bid dosing
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsAvoid contact with mucous membranes, eyes, mouth, and nostrils; avoid exposure to sunlight and sunlamps; dryness of skin, scaling, erythema, burning, and pruritus may occur



Deterrence/Prevention

Measures should be taken to prevent excessive skin dryness. Mild soaps and cleansers should be used. Frequent application of emollients is very beneficial.

Complications

Complications are infrequent. However, postinflammatory hypopigmentation or hyperpigmentation and scarring may occur.

Prognosis

Overall prognosis is good. Many cases resolve with increasing age. However, others may persist into late adulthood with intermittent exacerbations and remissions.

Patient Education

Patient education should focus on the tendency for chronicity of the condition and the need for ongoing maintenance therapy. Patients should also be advised that the condition is not contagious and is not a threat to their overall health. For excellent patient education resources, visit eMedicine's Skin, Hair, and Nails Center.



Media file 1:  Close-up view of keratosis pilaris. Keratotic follicular-based erythematous papules are noted on upper arm.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Keratosis pilaris in characteristic location on outer upper arm of a 30-year-old woman.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  1. Sardana K, Relhan V, Garg V, Khurana N. An observational analysis of erythromelanosis follicularis faciei et colli. Clin Exp Dermatol. Jan 11 2008;[Medline].
  2. Augustine M, Jayaseelan E. Erythromelanosis follicularis faciei et colli: relationship with keratosis pilaris. Indian J Dermatol Venereol Leprol. Jan-Feb 2008;74(1):47-9. [Medline].
  3. Mevorah B, Marazzi A, Frenk E. The prevalence of accentuated palmoplantar markings and keratosis pilaris in atopic dermatitis, autosomal dominant ichthyosis and control dermatological patients. Br J Dermatol. Jun 1985;112(6):679-85. [Medline].
  4. Jackson JB, Touma SC, Norton AB. Keratosis pilaris in pregnancy: an unrecognized dematosis of pregnancy?. W V Med J. Jan-Feb 2004;100(1):26-8. [Medline].
  5. Kragballe K, Steijlen PM, Ibsen HH, van de Kerkhof PC, Esmann J, Sorensen LH, et al. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study. Arch Dermatol. May 1995;131(5):556-60. [Medline].
  6. Bielan B. What's your assessment? Keratosis pilaris. Dermatol Nurs. Aug 2004;16(4):357-8. [Medline].
  7. Lateef A, Schwartz RA. Keratosis pilaris. Cutis. Apr 1999;63(4):205-7. [Medline].
  8. Novick NL. Practical management of widespread, atypical keratosis pilaris. J Am Acad Dermatol. Aug 1984;11(2 Pt 1):305-6. [Medline].
  9. Poskitt L, Wilkinson JD. Natural history of keratosis pilaris. Br J Dermatol. Jun 1994;130(6):711-3. [Medline].

Keratosis Pilaris excerpt

Article Last Updated: Mar 7, 2008